Radiotherapy Side Effect
111
38
41
27
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
3 terminated out of 111 trials
90.0%
+3.5% vs benchmark
5%
5 trials in Phase 3/4
0%
0 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (111)
CPAP or BiPAP for Motion Mitigation During Radiotherapy
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK)
Curatively Intended Thoracic Reirradiation
Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
Early Diagnosis and Cardiovascular Risk Stratification in Children Exposed to Cancer Therapies
Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)
DENTOFACIAL-PBT Stage 2 - Feasibility Study
RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
Manual Lymph Drainage for External Lymphedema
Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma
Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.
Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
Health Oriented Protocol for Epidermal Radiodermatitis
Longitudinal Registry Including Patients Treated With Heavy Particles
SMC Radiation Oncology Breast Cancer Cohort Study
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients